Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

ATRC
AtriCure, Inc.
stock NASDAQ

At Close
Sep 18, 2026 3:59:55 PM EDT
58.15USD-1.641%(-0.97)8,670,313
0.00Bid   0.00Ask   0.00Spread
Pre-market
Sep 18, 2026 9:29:59 AM EDT
58.83USD-0.482%(-0.29)669
After-hours
Sep 18, 2026 4:29:30 PM EDT
58.10USD-0.090%(-0.05)84,761
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 25, 2022
08:00AM EST  AtriCure to Announce Fourth Quarter and Full Year 2021 Financial Results   Business Wire
Jan 10, 2022
07:28AM EST  AtriCure Sees Q4 Sales ~$73.2M Vs. $72.53M Est., FY22 Sales $315M-$330M Vs. $321.67M Est.   Benzinga
07:10AM EST  AtriCure Q4 Prelim. Revenue Up 27% To $73.2 Mln   RTTNews
07:00AM EST  AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022   Business Wire
Dec 20, 2021
08:00AM EST  AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference   Business Wire
Nov 12, 2021
08:00AM EST  AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference   Business Wire
Nov 4, 2021
05:44AM EDT  Needham Maintains Buy on AtriCure, Raises Price Target to $92   Benzinga
05:25AM EDT  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $110   Benzinga
Nov 3, 2021
07:02PM EDT  UPDATE: AtriCure Q3 Adj. EPS $(0.23) Beats $(0.33) Estimate   Benzinga
04:20PM EDT  AtriCure Reaffirms FY21 Guidance   Benzinga
04:20PM EDT  AtriCure Q3 EPS $2.11 Up From $(0.11) YoY, Sales $70.50M Beat $68.68M Estimate   Benzinga
04:02PM EDT  AtriCure Reports Third Quarter 2021 Financial Results   Business Wire
09:19AM EDT  The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering   Benzinga
09:10AM EDT  Earnings Scheduled For November 3, 2021   Benzinga
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 26, 2021
08:00AM EDT  AtriCure to Participate in Upcoming Investor Conferences   Business Wire
Oct 5, 2021
08:00AM EDT  AtriCure to Announce Third Quarter 2021 Financial Results   Business Wire
Aug 31, 2021
08:00AM EDT  AtriCure to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference   Business Wire
Aug 20, 2021
01:55PM EDT  Return on Capital Employed Insights for AtriCure   Benzinga
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 5, 2021
10:07AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021   Benzinga
08:03AM EDT  Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $120   Benzinga
07:41AM EDT  Oppenheimer Downgrades AtriCure to Perform   Benzinga
05:53AM EDT  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $100   Benzinga
05:43AM EDT  Needham Maintains Buy on AtriCure, Lowers Price Target to $90   Benzinga
Aug 4, 2021
04:33PM EDT  AtriCure Sees FY21 Sales $270M-$275M Vs. $254.77M Est.   Benzinga
04:32PM EDT  AtriCure Q2 EPS $(0.30) Beats $(0.33) Estimate, Sales $71.38M Beat $61.07M Estimate   Benzinga
04:01PM EDT  AtriCure Reports Second Quarter 2021 Financial Results   Business Wire
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Aug 3, 2021
07:55AM EDT  The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business   Benzinga
Jul 30, 2021
08:00AM EDT  AtriCure to Participate at the Canaccord 41st Annual Growth Conference   Business Wire
Jul 13, 2021
08:05AM EDT  The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data   Benzinga
Jul 9, 2021
07:36AM EDT  The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO   Benzinga
Jul 8, 2021
07:45AM EDT  The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test   Benzinga
Jul 7, 2021
08:00AM EDT  AtriCure to Announce Second Quarter 2021 Financial Results   Business Wire
Jun 29, 2021
08:17AM EDT  The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout   Benzinga
Jun 15, 2021
07:07AM EDT  AtriCure Names Deborah Telman And Maggie Yuen To Board   RTTNews
07:00AM EDT  AtriCure Names Two New Members to the Board of Directors   Business Wire
May 26, 2021
08:54AM EDT  Expert Ratings for AtriCure   Benzinga
08:32AM EDT  10 Biggest Price Target Changes For Wednesday   Benzinga
06:09AM EDT  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $95   Benzinga
May 14, 2021
09:43AM EDT  JP Morgan Maintains Overweight on AtriCure, Raises Price Target to $81   Benzinga
Apr 30, 2021
09:20AM EDT  Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $102   Benzinga
07:31AM EDT  The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs   Benzinga
Apr 29, 2021
11:48AM EDT  CORRECTION: Credit Suisse maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $81 to $91 - Correct Analyst Firm Needham   Benzinga
11:44AM EDT  Credit Suisse Maintains Buy on AtriCure, Raises Price Target to $91   Benzinga
07:13AM EDT  AtriCure Reports Its EPi-Sense System Approved By FDA For Treatment Of Long-Standing Persistent Afib Patients   Benzinga
07:05AM EDT  AtriCure's EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients   Benzinga
Apr 28, 2021
07:58AM EDT  Oppenheimer Maintains Outperform on AtriCure, Raises Price Target to $75   Benzinga
07:08AM EDT  Needham Maintains Buy on AtriCure, Raises Price Target to $81   Benzinga
Apr 27, 2021
04:37PM EDT  AtriCure: Q1 Earnings Insights   Benzinga
04:18PM EDT  AtriCure Sees FY21 Sales $252M-$256M Vs. $250.29M Est.   Benzinga
04:17PM EDT  AtriCure Q1 EPS $(0.32) Beats $(0.37) Estimate, Sales $59.30M Beat $56.06M Estimate   Benzinga
04:01PM EDT  AtriCure Reports First Quarter 2021 Financial Results   Business Wire
07:41AM EDT  The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout   Benzinga
04:05AM EDT  Earnings Scheduled For April 27, 2021   Benzinga
Apr 26, 2021
10:37AM EDT  Preview: AtriCure's Earnings   Benzinga
Apr 24, 2021
09:24AM EDT  The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx   Benzinga
Apr 23, 2021
07:28AM EDT  The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs   Benzinga
Apr 21, 2021
07:31AM EDT  The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue   Benzinga
Apr 20, 2021
08:07AM EDT  The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex   Benzinga
Apr 8, 2021
08:12AM EDT  AtriCure Names B. Kristine Johnson Board Chair   Benzinga
Apr 6, 2021
08:00AM EDT  AtriCure to Announce First Quarter 2021 Financial Results   Business Wire
Mar 2, 2021
04:01PM EST  AtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference   Business Wire
08:01AM EST  The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data   Benzinga
Feb 24, 2021
07:47AM EST  10 Biggest Price Target Changes For Wednesday   Benzinga
07:30AM EST  The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO   Benzinga
06:14AM EST  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $78   Benzinga
05:29AM EST  Needham Maintains Buy on AtriCure, Raises Price Target to $74   Benzinga
Feb 23, 2021
04:25PM EST  AtriCure: Q4 Earnings Insights   Benzinga
04:04PM EST  Atricure Sees Q1 Sales $55M-$57M vs $59.3M Estimate, Adj. EPS $(0.39)-$(0.36)   Benzinga
04:03PM EST  Atricure Sees FY21 Adj. EBITDA Loss $10M, Adj. EPS $(1.15), Sales ~$250M   Benzinga
04:02PM EST  AtriCure Q4 Adj. EPS $(0.18) Beats $(0.28) Estimate, Sales $57.70M Miss $58.10M Estimate   Benzinga
04:01PM EST  AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results   Business Wire
07:25AM EST  The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts   Benzinga
04:09AM EST  Earnings Scheduled For February 23, 2021   Benzinga
Feb 22, 2021
10:19AM EST  Earnings Preview: AtriCure   Benzinga
Feb 11, 2021
11:21AM EST  Stocks That Hit 52-Week Highs On Thursday   Benzinga
Feb 10, 2021
08:00AM EST  AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference   Business Wire
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Feb 3, 2021
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
Feb 2, 2021
08:00AM EST  AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results   Business Wire
Jan 28, 2021
08:03AM EST  The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO   Benzinga
Jan 22, 2021
09:51AM EST  Needham Maintains AtriCure as Top Small/Mid-Cap Pick; Warns on Lower Revenue for Q4 Following Management Preannouncement However Highlights Upcoming Data from aMAZE Trial within Late 2021 as Major Catalyst with Near-Term Growth Driven by New Products   Benzinga
Jan 13, 2021
07:25AM EST  The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations   Benzinga
Jan 12, 2021
08:16AM EST  The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue   Benzinga
Jan 11, 2021
07:24AM EST  AtriCure Sees Q4 Sales $57.7M Vs. $58.1M Est.   Benzinga
07:21AM EST  AtriCure Sees Q4 Revenue At About $57.7 Mln, Down 6% From Last Year   RTTNews
07:00AM EST  AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020   Business Wire
Jan 4, 2021
08:10AM EST  AtriCure Announces Labeling Expansion For Cryo Nerve Block Therapy   Benzinga
Dec 29, 2020
08:09AM EST  The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica   Benzinga
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 22, 2020
07:45AM EST  The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes   Benzinga
Dec 18, 2020
07:48AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data   Benzinga
07:45AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data   Benzinga
Dec 14, 2020
08:00AM EST  AtriCure to Participate in the 39th Annual J.P. Morgan Healthcare Conference   Business Wire
05:26AM EST  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $65   Benzinga
Nov 19, 2020
11:44AM EST  Insider Buys AtriCure Stock   Benzinga
08:00AM EST  AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference   Business Wire
Nov 6, 2020
05:40AM EST  Needham Maintains Buy on AtriCure, Lowers Price Target to $53   Benzinga
Nov 5, 2020
04:20PM EST  AtriCure Q3 EPS $(0.11) Up From $(0.33) YoY, Sales $54.76M Beat $49.37M Estimate   Benzinga
04:01PM EST  AtriCure Reports Third Quarter 2020 Financial Results   Business Wire
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 26, 2020
08:00AM EDT  AtriCure to Participate in Upcoming Investor Conferences   Business Wire
Oct 13, 2020
08:00AM EDT  AtriCure to Announce Third Quarter 2020 Financial Results   Business Wire
Sep 30, 2020
10:44AM EDT  Shares of AtriCure Inc. (ATRC) are falling more than 5 percent or $2.10 in Wednesday's morning trade at $37.92.   RTTNews
Sep 1, 2020
08:00AM EDT  AtriCure to Participate at the Morgan Stanley 18th Annual Global Healthcare Conference   Business Wire
Aug 6, 2020
04:00PM EDT  AtriCure Announces Angie Wirick as Chief Financial Officer   Benzinga
Jul 29, 2020
01:32PM EDT  JP Morgan Maintains Overweight on AtriCure, Raises Price Target to $57   Benzinga
12:15PM EDT  Piper Sandler Maintains Overweight on AtriCure, Raises Price Target to $50   Benzinga
08:00AM EDT  AtriCure to Participate at Upcoming Investor Conferences   Business Wire
06:40AM EDT  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $60   Benzinga
Jul 28, 2020
04:23PM EDT  Recap: AtriCure Q2 Earnings   Benzinga
04:05PM EDT  AtriCure Q2 EPS $(0.38) Beats $(0.61) Estimate   Benzinga
04:01PM EDT  AtriCure Reports Second Quarter 2020 Financial Results   Business Wire
04:05AM EDT  Earnings Scheduled For July 28, 2020   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC